Bottom line
How much do FTXH and LYFIX overlap?
21% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 25.7% of FTXH's assets and 25.1% of LYFIX's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings FTXH and LYFIX have in common
| Holding | % of FTXH | % of LYFIX | Overlap |
|---|---|---|---|
| Abbvie Inc ABBV | 7.39% | 1.95% | 1.95% |
| Biogen Inc BIIB | 3.84% | 1.80% | 1.80% |
| Vertex Pharmaceuticals Inc VRTX | 3.41% | 5.33% | 3.41% |
| Amgen Inc AMGN | 3.18% | 1.83% | 1.83% |
| Gilead Sciences Inc GILD | 2.89% | 5.53% | 2.89% |
| Incyte Corp INCY | 2.39% | 3.51% | 2.39% |
| Neurocrine Biosciences Inc NBIX | 1.37% | 3.51% | 1.37% |
| Halozyme Therapeutics Inc HALO | 1.21% | 1.58% | 1.21% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FTXH
- Eli Lilly & Company — 7.77%
- Merck & Company Inc — 7.07%
- Johnson & Johnson — 6.96%
- Bristol-myers Squibb Company — 6.29%
- Viatris Inc — 3.62%
- Cardinal Health Inc — 3.53%
- Pfizer Inc — 2.97%
- United Therapeutics Corp — 2.72%
- Regeneron Pharmaceuticals Inc — 2.72%
- Jazz Pharmaceuticals Plc — 2.49%
- Illumina Inc — 1.98%
- Zoetis Inc — 1.87%
- Exelixis Inc — 1.72%
- Charles River Laboratories International Inc — 1.49%
- Medpace Holdings Inc — 1.41%
Only in LYFIX
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
- Ionis Pharmaceuticals Inc — 2.62%
- Ascendis Pharma A/s — 2.62%
- Insmed Inc — 2.60%
- Protagonist Therapeutics Inc — 2.41%
- Personalis Inc — 2.27%
- Rhythm Pharmaceuticals Inc — 2.25%
- Jazz Pharmaceuticals Plc — 1.87%
- Catalyst Pharmaceuticals Inc — 1.59%
- Meiragtx Holdings Plc — 1.58%
Asset mix
| Asset type | FTXH | LYFIX |
|---|---|---|
| Stocks | 99.9% | 95.8% |
| Cash & short-term funds | 0.1% | 4.3% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | FTXH | LYFIX |
|---|---|---|
| US | 95.6% | 76.0% |
| NL | — | 4.7% |
| GB | — | 4.6% |
| IE | 3.8% | 2.4% |
| BM | 0.6% | 3.7% |
| FR | — | 2.8% |
| DK | — | 2.6% |
| KY | — | 1.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FTXH and LYFIX overlap?
What stocks do FTXH and LYFIX have in common?
Should I own both FTXH and LYFIX?
Which holds more stocks, FTXH or LYFIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.